, Columnists
Thomas H. Lee’s InVentiv Said to Pursue Sale as Well as IPO
This article is for subscribers only.
InVentiv Group Holdings Inc., the health-care company backed by Thomas H. Lee Partners that filed for an initial public offering in April, is now also pursuing an outright sale, according to people with knowledge of the matter.
The company and its advisers are having active discussions with potential strategic and private equity acquirers, said the people, who asked not to be identified because the information is private. Exploring a sale while planning to go public, known as a dual-track process, is a way for owners to gauge the best way to exit an investment.